Qualigen Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aixcrypto Holdings

16/08/2021 23:39

* Qualigen Therapeutics Inc  QLGN.OQ  reported a quarterly
adjusted loss of 18 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 16 cents per share.
* Revenue was $1.12 million​;  analysts expected $1.40 million. 
* Qualigen Therapeutics Inc's reported EPS for the quarter was a
loss of 18 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Qualigen Therapeutics Inc shares had fallen by 10.6% this
quarter and lost 40.9% so far this year.
* The company reported a quarterly loss of $5.31 million.
* Wall Street's median 12-month price target for Qualigen
Therapeutics Inc is $9.75 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 10:39 p.m.  ​All
figures in US dollars unless otherwise stated